ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
55 hedge funds and large institutions have $10M invested in Oncternal Therapeutics, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 18 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
51% less call options, than puts
Call options by funds: $139K | Put options by funds: $284K
Holders
55
Holding in Top 10
–
Calls
$139K
Puts
$284K
Top Buyers
| 1 | +$302K | |
| 2 | +$294K | |
| 3 | +$182K | |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$148K |
| 5 |
ProShare Advisors
Bethesda,
Maryland
|
+$41K |
Top Sellers
| 1 | -$805K | |
| 2 | -$202K | |
| 3 | -$188K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$168K |
| 5 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$100K |